EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,607 | +13.2% | 67 | +3.1% | 0.00% | – |
| Q3 2023 | $1,420 | +7.7% | 65 | -5.8% | 0.00% | – |
| Q2 2023 | $1,319 | -1.5% | 69 | 0.0% | 0.00% | – |
| Q1 2023 | $1,339 | +103.5% | 69 | +68.3% | 0.00% | – |
| Q4 2022 | $658 | -96.5% | 41 | -95.7% | 0.00% | -100.0% |
| Q4 2020 | $19,000 | – | 950 | – | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $13,000 | +18.2% | 550 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | +10.0% | 550 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $10,000 | -16.7% | 550 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $12,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |